Novo Nordisk has said it is discontinuing selling its popular, best-selling insulin brand in India and will instead promote ...

Danish pharmaceutical giant Novo Nordisk has announced plans to phase out Human Mixtard, India's top-selling insulin brand.

(CNN) - The Food and Drug Administration is warning of fake Ozempic that could pose a safety risk. The FDA and Ozempic ...

Novo Nordisk will discontinue Human Mixtard, a top-selling insulin in India. This decision aligns with the company's global ...

In this edition of Daily Dose, Dr. Lacy Anderson answers a viewer's question about what discounts are available for weight ...

LUBBOCK, Texas (KCBD) - The Federal Drug Administration is warning of fake Ozempic, saying it could pose a safety risk. The ...

In December, the agency said it seized thousands of units of fake Ozempic and warned that some may still be available for ...

In a move which could shake up the diabetes market, Novo Nordisk is discontinuing the country’s largest selling insulin, ...

The FDA and Ozempic manufacturer Novo Nordisk have found counterfeit vials of the weight-loss drug being sold to consumers. The labels on the counterfeit products have a real lot number “PAR0362 ...

The India launch of Eli Lilly’s popular weight-loss drug Mounjaro has triggered a huge wave of patient enquiries about its ...

New research found hospital visits from Ozempic and Wegovy are rare, but can be serious. Experts explain the finding and ...

Tirzepatide (Mounjaro) launched in India in March 2025, promising new hope for diabetes and obesity treatment. An expert ...